Current SARS-CoV-2 surveillance from WHO and national health agencies shows the virus circulating at endemic levels in 2026, with modest case increases in regions like India and low global test positivity, driven by variants such as XFG under monitoring rather than any novel strain exhibiting pandemic-scale transmissibility or virulence. Widespread population immunity from prior infection and vaccination, combined with available therapeutics, has kept hospitalizations and deaths far below thresholds that would trigger a Public Health Emergency of International Concern. Trader consensus at 96% for no new coronavirus pandemic reflects this sustained epidemiological stability and absence of concerning zoonotic spillovers. A realistic shift could occur if genomic surveillance detects a highly immune-evasive variant with elevated severity, prompting rapid model revisions from agencies like the CDC or WHO.